Key result
Dynamic cardiomyoplasty improves end-systolic elastance by ~54% versus controls in a canine heart failure model.
Why the study?
Dynamic cardiomyoplasty is an alternative therapy for end-stage heart failure, but the acute and chronic mechanisms by which it affects left ventricular function were not fully understood.
Does dynamic cardiomyoplasty improve left ventricular function in a canine model of pacing-induced dilated cardiomyopathy?
RCT (n=19)
randomly selected
Does dynamic cardiomyoplasty improve left ventricular function in a canine model of pacing-induced dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Dynamic cardiomyoplasty improves ventricular function in a canine heart failure model through both the girdling effect of the muscle wrap and active systolic assistance.
OBJECTIVES: Dynamic cardiomyoplasty is an alternative therapy for end-stage heart failure. We investigated the mechanisms, both acute and chronic, by which a synchronously stimulated conditioned muscle wrap affects left ventricular function in a chronic canine model of dilated cardiomyopathy. METHODS: Nineteen dogs underwent rapid ventricular pacing at a rate of 215 beats/min for 4 weeks to create a model of heart failure. Eight dogs were then randomly selected to undergo cardiomyoplasty, and all dogs received 6 additional weeks of rapid ventricular pacing. The cardiomyoplasty group also received a graded muscle conditioning protocol of synchronized burst stimulation to transform the muscle wrap. All dogs were studied with pressure-volume analysis and echocardiography at baseline and after 4 and 10 weeks of rapid ventricular pacing. Data in the cardiomyoplasty group were analyzed with the stimulator off, with it augmenting every beat (1:1), and with it augmenting only every other beat (1:2). RESULTS: Stimulator "of" data at 10 weeks of rapid pacing demonstrated chronic effects by enhanced ventricular function (end-systolic elastance = 1.80 after myoplasty vs 1.17 for controls, p = 0.005) and a stabilization of volumes and composite end-systolic and end-diastolic pressure-volume relations in the cardiomyoplasty group when compared with controls. Myoplasty stimulation increased apparent contractility (preload recruitable stroke work = 31.3 for stimulator "of" vs 40.6 for stimulator 1:2 assisted beats [p < 0.05] and vs 45.4 for stimulator 1:1 [p < 0.05]). CONCLUSIONS: Benefits from dynamic cardiomyoplasty are by at least two mechanisms: (1) the girdling effects of a conditioned muscle wrap, which halts the chronic remodeling of heart failure, and (2) active systolic assistance, which augments the apparent contractility of the failing heart.
No takes yet. Share an insight, caveat, or question.
Patel et al. (1997) conducted an RCT in dilated cardiomyopathy (canine model) (n=19). Dynamic cardiomyoplasty vs. Control (rapid ventricular pacing only) was evaluated on End-systolic elastance at 10 weeks (p=0.005). Dynamic cardiomyoplasty improved end-systolic elastance compared to controls in a canine model of heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: